On Invalid Date, Enfusion (NYSE: ENFN) reported Q1 2023 earnings per share (EPS) of $0.04, up 140% year over year. Total Enfusion earnings for the quarter were $2.95 million. In the same quarter last year, Enfusion's earnings per share (EPS) was -$0.10.
On Invalid Date, Enfusion (NYSE: ENFN) reported Q1 2023 revenue of $40.97 million up 20.01% year over year. In the same quarter last year, Enfusion's revenue was $34.14 million.
What was ENFN's revenue growth in the past year?
As of Q2 2023, Enfusion's revenue has grown 29.38% year over year. This is 3.46 percentage points lower than the US Software - Application industry revenue growth rate of 32.83%. Enfusion's revenue in the past year totalled $157.18 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.